Clinical trial site operations insights

Practical guidance from the site side of clinical research.

Field notes on the operating decisions that shape study start-up, patient enrollment, quality, monitoring follow-up, and portfolio performance.

Featured guide
Clinical trial enrollment

Why GU clinical trials stall at screening—and the first three things to change

How to find where eligible patients are lost between identification, prescreening, approach, consent, and enrollment.

Sierra Williams Thomson · 9 min read
What we write about

Site problems that can actually be diagnosed.

Merindale focuses on work close to trial execution: feasibility, start-up, participant flow, monitoring follow-up, quality, team ownership, and study workflow.

The goal is not to publish commentary for its own sake. Each guide should help a research leader ask a better operating question, see a process more clearly, or avoid a preventable mistake.

About the experience behind the writing →

Editorial standard

Write from the work, not around it.

Every guide is tied to areas informed by hands-on site-side clinical research experience. When a factual statement needs outside support, we link to a primary source, peer-reviewed paper, regulator, or credible industry reference rather than hiding the source behind vague language.

We also separate experience from evidence. “This is what I would look at first” is different from “research shows.” Readers should be able to tell which is which.

The writing is intentionally practical: real operating questions, concrete examples, clear limitations, and internal links that help a reader move from a problem to the related service or deeper guide.

Read our professional standards →

Have a site problem worth unpacking?

If your study is delayed, under-enrolling, carrying repeat findings, or relying on fragile workarounds, start with the operating problem.